POZ uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy
POZ uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.
Sean Strub
The unanswered question in this story is whether the study found a differential in fracture risk between those with HIV and CD4 cells higher than 350 who were on treatment and those with HIV and CD4 cells higher than 350 who were not on treatment.
October 13, 2010 • New York